Showing 1 - 9 results of 9 for search '"PTEN (gene)"', query time: 0.04s Refine Results
  1. 1

    PTEN Gene: A Model for Genetic Diseases in Dermatology by Corrado Romano, Carmelo Schepis

    Published 2012-01-01
    “…PTEN gene is considered one of the most mutated tumor suppressor genes in human cancer, and it’s likely to become the first one in the near future. …”
    Get full text
    Article
  2. 2
  3. 3

    PI3K/AKT/PTEN Signaling as a Molecular Target in Leukemia Angiogenesis by Naoko Okumura, Hitomi Yoshida, Yasuko Kitagishi, Mutsumi Murakami, Yuri Nishimura, Satoru Matsuda

    Published 2012-01-01
    “…The signaling pathway is activated in leukemia patients as well as leukemia cell lines together with a decrease in the expression of PTEN gene. The mechanism by which the signaling pathway regulates angiogenesis remains to be further elucidated. …”
    Get full text
    Article
  4. 4

    lncRNA HOTTIP Recruits EZH2 to Inhibit PTEN Expression and Participates in IM Resistance in Chronic Myeloid Leukemia by Jing Liu, Lin Yang, Xiaojun Liu, Lu Liu, Menghan Liu, Xuefeng Feng, Jianmin Luo

    Published 2022-01-01
    “…To investigate that HOTTIP suppressed PTEN gene expression and was involved in IM resistance in chronic myeloid leukemia through recruitment of EZH2 protein. …”
    Get full text
    Article
  5. 5

    <i>CCND1</i> and <i>PTEN</i> genes as markers of progression in vulvar cancer by A. V. Busarova, N. A. Petrusenko, P. A. Kruze, N. V. Porhanova

    Published 2023-12-01
    “…In the 2nd group of patients, a statistically significant 1.7-fold increase in RCQ of the CCND1 gene (p &lt; 0.05) and a 1.9-fold decrease in RCQ of the PTEN gene (p &lt; 0.05) were found.Conclusion. In the study, CCND1 amplification events and/or PTEN loss were associated with lymph node metastasis in RV patients. …”
    Get full text
    Article
  6. 6

    Complex immunohistochemical and molecular study on 5 cases of ovarian juvenile granulosa cell tumors reveals a consistent alteration in the PI3K/AKT/mTOR signaling pathway by Adam Šafanda, Nikola Hájková, Michaela Kendall Bártů, Marián Švajdler, Radoslav Matěj, Jitka Hausnerová, Tomáš Zima, Pavel Dundr, Kristýna Němejcová

    Published 2025-01-01
    “…However, no mutations, deletions (as assessed by CNV analysis), or promoter hypermethylation in the PTEN gene were detected. Conclusion The results of our study further support the hypothesis that the pathogenesis of JGCT may be driven by activation of the PIK3/AKT/mTOR pathway. …”
    Get full text
    Article
  7. 7

    PTEN Sequence Analysis in Endometrial Hyperplasia and Endometrial Carcinoma in Slovak Women by H. Gbelcová, P. Bakeš, P. Priščáková, V. Šišovský, I. Hojsíková, Ľ. Straka, M. Konečný, J. Markus, C. W. D’Acunto, T. Ruml, D. Böhmer, Ľ. Danihel, V. Repiská

    Published 2015-01-01
    “…Formalin-fixed and paraffin-embedded tissue samples with simple hyperplasia (3), complex hyperplasia (5), atypical complex hyperplasia (7), endometrioid carcinomas G1 (20) and G3 (5), and serous carcinoma (5) were evaluated for the presence of mutations in coding regions of PTEN gene, the most frequently mutated tumor suppressor gene in endometrial carcinoma. 75% of the detected mutations were clustered in exons 5 and 8. …”
    Get full text
    Article
  8. 8

    Effect of miR-144-3p-Targeted Regulation of PTEN on Proliferation, Apoptosis, and Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells under Stretch by Shiyong Ling, Xi Luo, Bo Lv, Hua Wang, Mengzhi Xie, Kai Huang, Jingchuan Sun

    Published 2022-01-01
    “…To investigate the effects of miR-144-3p-targeted regulation of phosphatase and tensin homolog deleted on chromosome ten (PTEN) gene on proliferation, apoptosis, and osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) under retraction force. …”
    Get full text
    Article
  9. 9

    Efficacy of Next-Generation Sequencing in Identifying Genetic Markers for Prostate Cancer Risk by Fahad H. Alaithan, Raghad H. Alaithan, Tauheed Ahmed

    Published 2024-12-01
    “…Furthermore, CNVs in the MYC and PTEN genes were observed in 15% and 10% of the patients, respectively. …”
    Get full text
    Article